C.R. Bard, Inc. (NYSE:BCR) has been the object of insider selling activity recently. Group President Timothy P. Collins sold 55,818 shares at an average price of $322.03 on Thu the 12th. That brings the Group President’s holdings to $8,580,811 as reported to the SEC. Frank Jr Lupisella, VP sold $2,981,225 worth of shares at an average price of $325.00 on October 18th. The VP now owns $3,304,941 of the stock as recorded in a recent Form 4 SEC filing.
Betty D. Larson, VP sold $1,949,925 worth of shares at an average price of $330.16 on Fri the 20th. That brings Larson’s holdings to $2,773,014 per an SEC filing yesterday.
C. R. Bard, Inc. (Bard), incorporated in 1923, is involved in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. The Company sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. The Company reports its sales in four product group categories: vascular, urology, oncology and surgical specialty. The Company also has a product group of other products. As of December 31, 2016, the Company, through its subsidiaries, marketed its products to customers in over 100 countries outside the United States. The Business’s principal international markets are in Europe, Japan and China..
Additionally, here are a few investment firms who have increased or decreased their stake in (BCR). As of quarter end Farmers & Merchants Investments Inc had acquired 9 shares growing its stake by 0.1%. The value in dollars increased from $3,800,000 to $3,855,000 a change of $55,000 for the reporting period. Harvey Investment Co LLC downsized its position by selling 1,063 shares a decrease of 6.0% as of 09/30/2017. Harvey Investment Co LLC controls 16,612 shares valued at $5,324,000. The value of the position overall is down by 4.7%.
As of the end of the quarter State Treasurer State Of Michigan had sold a total of 1,700 shares trimming its position 7.1%. The value of the investment in C.R. Bard, Inc. went from $7,516,000 to $7,076,000 a change of 5.9% quarter over quarter. Robeco Institutional Asset Management B.v. divested its holdings by shedding 5,903 shares a decrease of 51.6%. Robeco Institutional Asset Management B.v. now controls 5,527 shares worth $1,771,000. The total value of its holdings decreased 51.0%.
The company is trading up by 0.02%% since yesterday’s close of 328.14. Additionally the company declared a dividend for shareholders that will be paid on Friday the 29th of December 2017. The dividend payment will be $0.260 per share for the quarter which comes to $1.04 on an annualized basis. This dividend represents a yield of $0.31 which is the dividend as a percentage of the current share price. The ex-dividend date is Thursday the 20th of July 2017.
Shares last traded at $328.21 slightly over $321.61, the stock’s 50 day moving average and which is marginally over the 200 day moving average of $311.84. The 50 day moving average went up $6.60 or +2.05% whereas the 200 day moving average was up $16.37 or +5.25%.
C.R. Bard, Inc.’s P/E ratio is 43.09 and the market value is 23.85B. As of the last earnings report the EPS was $7.62 and is estimated to be $11.84 for the current year with 72,671,000 shares outstanding. Next quarter’s EPS is estimated at $3.14 with next year’s EPS anticipated to be $12.97.
Investors are more bearish on C.R. Bard, Inc. if you consider the uptick in short interest. The stock had a rise in short interest of 23.19% between September 15, 2017 and September 29, 2017. Short interest grew from 985,554 to 1,214,137 over that timeframe. The short-interest ratio decreased to 3.0 and the short interest percentage is 0.02% as of September 29.